Ben Inker appears on episode 183 of the Meb Faber Show in what Meb describes as “one of his favorite chats all year”.
Episode #183: Ben Inker, “The Problem With Good Returns In The Near Term Is They Have To Be Paid Back Sometime”
The Economist September 21, 2019
Jeremy Grantham, Long-Term Investment Strategist and Co-Founder of GMO, was profiled alongside Bill Gates, Elon Musk, and Michael Bloomberg in The Economist’s recent Climate Issue as one of twelve leaders focusing on Climate Change. The article correctly states that Jeremy expects significant returns in the decade ahead from climate-friendly investments. GMO’s Climate Change Strategy was launched in 2017, and looks to invest in companies focused on mitigating the impacts of and adapting to the outcomes of climate change. To read the article, please click here.
GMO Wins Multiple Lipper Fund Awards 2019 United States
GMO receives awards for GMO Quality Fund, GMO Emerging Country Debt Fund, GMO Special Opportunity Fund and is a trophy winner for GMO Resources Fund. Winners are rewarded for consistency over time, including the top 3-year, 5-year and 10-year funds, as well as trophy winners across 10 distinct categories. Please note that these are not Lipper Rankings. More information, including methodology can be found at www.lipperfundawards.com. To learn more, click here (subscription required).
Jeremy Grantham on CNBC’s Closing Bell March 7, 2019
CNBC's Wilfred Frost sits down with Jeremy Grantham to talk about markets and the global economy. To view interview, click here.
Financial Times October 29, 2019
FT Alphaville features Pete Chiapinelli’s presentation on the “Passive Aggressive ‘Agg” from the annual conference hosted by Grant's Interest Rate Observer ("The Agg-grevated index", [registration required for access], by Jamie Powell).
Australian Financial Review September 25, 2019
GMO head of Focused Equity Tom Hancock comments on the investment outlook ("Bond market feeling 'bubbly' says Hancock," by Sarah Turner).
The Globe & Mail (Toronto) September 4, 2019
"GMO asset manager Ben Inker adds his voice to chorus of concern regarding the outlook for U.S. companies" ("Is it time to look beyond Wall Street's giants?" [subscription required for access], by Ian McGugan).
Citywire September 2, 2019
Columnist examines long-term prospects for retirement investors, citing GMO asset-class forecasts ("David Stevenson: a wake-up call for portfolio projections").
Institutional Investor August 22, 2019
Rick Friedman of GMO's Asset Allocation team: "GMO's seven-year asset class forecasts for both stocks and bonds have generally declined in 2019, predominantly due to strong appreciation in asset prices" ("GMO Says Emerging Markets Stocks Will Trounce U.S. Equities," by Christine Idzelis).
Financial Advisor August 19, 2019
John Pease of GMO's Asset Allocation team examines whether the underperformance of value relative to growth stocks in recent years indicates that the value premium has been eroded ("Grantham Mayo Analyzes Value Investing's House of Pain," by Evan Simonoff).
Financial Times August 13, 2019
Carl Ross of GMO's Emerging Country Debt team: "Argentina was already paying a premium on the bonds given its past defaults, and if it defaults again, it may get to a point where there is no price at which investors would consider owning Argentina" ("Argentina's Macri vows to win re-election amid market turmoil" [subscription required for access], by Benedict Mander, Colby Smith and Robin Wigglesworth).
The Wall Street Journal August 5, 2019
GMO portfolio strategist for emerging-markets equities Binu George: "Over the long term, ETFs are a net positive for investors and emerging markets" ("As Emerging Markets Recover, Here's What You Need to Know" [subscription required for access], by Bailey McCann).
Barron's July 25, 2019
Feature interview with James Montier on his view of modern monetary theory and the investment outlook ("Why a GMO Strategist Is Bearish on U.S. Stocks but Positive on Modern Monetary Theory" [subscription required for access], by Leslie Norton).
Morningstar July 10, 2019
James Montier interviewed by Morningstar head of global manager research Jeff Ptak and director of personal finance Christine Benz in 'The Long View' podcast ("Montier: 'How Do I Get Paid for Owning This Asset?'").
Bloomberg News July 9, 2019
GMO head of emerging country debt Tina Vandersteel comments on century bonds issued by Mexico and Argentina ("Century Bonds Having a Moment as JPMorgan, Pictet Load Up," by Ben Bartenstein).
Barron's July 8, 2019
GMO research referenced on the underperformance of value relative to growth stocks since 2006 ("Blue Chip Sale: 11 Bargain Stocks in a Pricey Market" [subscription required for access], by Jack Hough).
Financial Advisor July 1, 2019
Editor-in-chief Evan Simonoff cites Jeremy Grantham on the elevated stock valuations that have prevailed in the U.S. since 1997 ("How Deglobalization, Trade Could Slash Equity Multiples").
Barron's June 24, 2019
GMO ESG Practice Manager Hardik Shah on GMO's approach in sustainable investing ("The 100-Year Portfolio: How Sustainable Investing Has Grown Up" [subscription required for access], by Daren Fonda).
Citywire June 10, 2019
Martin Emery of GMO's Systematic Global Macro team on opportunities in global markets ("Is it time to back a global macro renaissance?," by Bailey McCann).
Barron's May 27, 2019
Peter Chiappinelli of GMO's Asset Allocation team comments on the market for negative-yielding debt ("The World Turned Upside Down: Five years of negative rates have left central bankers struggling to return to normalcy" [subscription required for access], by James Grant).
Institutional Investor May 9, 2019
Ben Inker: "It is almost certain that investors would achieve better overall outcomes if they recognized the risks outside of their portfolios that really matter and invested accordingly" ("GMO: Your Portfolio Obsession Is Forcing Bad Calls," by Christine Idzelis).
Financial Times May 9, 2019
Feature focuses on Jeremy Grantham's work on 'The Race of Our Lives' ("Jeremy Grantham on the battle to save society from climate change: 'We're not winning'" [subscription required for access], by Andrew Edgecliffe-Johnson).
Institutional Investor April 22, 2019
GMO co-founder Grantham sees profit in battling an existential threat ("Jeremy Grantham Says Investors Should Be 'Intrigued' by This Strategy," by Christine Idzelis).
The New York Times Magazine April 14, 2019
The Climate Issue: "An unsettling fact of Wall Street today is that some of the same people who accurately predicted the housing bubble are now describing another bubble, whose collapse will make the financial crisis of 2008 look mild" ("Hedging Against the Apocalypse," by Jesse Barron).
The New York Times April 7, 2019
James Montier cited among strategists finding merit in Modern Monetary Theory ("M.M.T. Gets an Embrace on Wall Street" [subscription required for access], by Patricia Cohen).
Advisor Perspectives April 5, 2019
In 'Gaining Perspective' podcast, ESG practice leader Hardik Shah discusses how GMO integrates environmental, social and governance factors into its investment processes ("GMO's Approach to ESG Investing").
Financial Times March 15, 2019
FT Alphaville examines the view from GMO Asset Allocation team members James Montier and Philip Pilkington that "so-called total factor productivity is not a measure of innovation at all" ("GMO's Montier on the rise of the dual economy" [registration for access], by Izabella Kaminska).
CNBC March 7, 2019
Anchor Wilfred Frost interviews GMO chief investment strategist Jeremy Grantham from the New York Stock Exchange in 25-minute extended version of segments that appeared on the 'Closing Bell' program ("The full interview with Jeremy Grantham").
Bloomberg February 22, 2019
GMO head of Emerging Country Debt Tina Vandersteel comments on GMO's process in emerging-market debt and the outlook for Venezuela, Tunisia, Turkey, Argentina, Mexico and Brazil ("Star Fund Manager Ignores the Sell Side to Beat Emerging-Market Rivals," by Ben Bartenstein).
Learn more about the Emerging Country Debt Fund.
Citywire February 11, 2019
Citywire profiles Jeremy Grantham on the state of capitalism, the imperative to confront climate change, and the investment opportunity in emerging markets ("'The capitalist beast is out of control': Jeremy Grantham takes aim at corporate culture," by Alex Steger).
ThinkAdvisor January 28, 2019
Q&A on investment outlook with GMO head of Asset Allocation Ben Inker ("GMO's Inker: Bullish on Medium Term, but Big Threats Loom," by Jane Wollman Rusoff).
Bloomberg Businessweek January 17, 2019
Jeremy Grantham: decarbonizing the economy will be "the biggest reshuffling of the economy since the Industrial Revolution" ("Investing Prophet Jeremy Grantham Takes Aim at Climate Change," by Ben Steverman).
Learn more about the Climate Change Fund.
Citywire January 9, 2019
Carl Ross of GMO's Emerging Country Debt team: Turkey and Argentina could prove big winners from a revival in emerging market debt over the course of 2019 ("Grantham's fund house reveals top post-crisis EMD calls," by Chris Sloley).
Barron's January 7, 2019
GMO Quality IV and GMO US Equity III recognized, Jeremy Grantham comments ("The Top Sustainable Funds" [subscription required for access], by Crystal Kim).
Learn more about the Quality Fund.
Learn more about the U.S. Equity Fund.
Institutional Investor January 2, 2019
Tom Hancock, head of GMO's Focused Equity team: "a technology-heavy portfolio can still be defensive if it is comprised of the right companies that meet our quality standards and trade at reasonable valuations" ("GMO Pitches a Curveball," by Christine Idzelis).
Bond Fund Intelligence December 2018
Editor interviews Tracey Keenan, GMO portfolio manager for Short Duration Strategies ("GMO's Tracey Keenan Talks Short Duration Strategies," by Peter Crane).
Bloomberg December 7, 2018
Bloomberg Opinion columnist Barry Ritholtz interviews Jeremy Grantham for the 'Masters in Business' series ("Jeremy Grantham Discusses Sustainable Investment").
Barron's December 3, 2018
GMO head of Asset Allocation Ben Inker "doesn't see much upside in U.S. stocks over a longer-term horizon because their valuation leaves little room for error" ("Stocks Spring Back to Life, Trade War or Not" [subscription required for access], by Ben Levisohn).
Fortune November 20, 2018
For the magazine's 2019 Investor's Guide, John Thorndike of GMO's Asset Allocation team comments on the outlook for emerging markets ("Why Emerging Markets are a Screaming Buy," by Shawn Tully) and Tom Hancock of the Focused Equity team discusses the approach to the financial sector for the GMO Quality Fund ("The 30 Best Stocks to Buy for 2019 -- in a Bull or Bear Market," by Jen Wieczner and Scott DeCarlo.
Bloomberg November 20, 2018
Neil Constable, head of GMO's Global Equity team, observes low-quality companies with corporate-governance red flags are trading at a premium to the market for the first time since the tech bubble ("The Stocks Rout Is Big, But Not Big Like the Beatles," by John Authers).
ThinkAdvisor November 6, 2018
John Thorndike comments on GMO's asset-class forecasts and relative value in emerging-market equities ("GMO Gives Long-Term View of Best Investments").
The Economist October 27, 2018
Buttonwood columnist quotes James Montier on the challenge of hewing to a value-investment strategy ("The agony of the value investor").
Financial Advisor October 23, 2018
Editor previews Jeremy Grantham's presentation to The SRI Conference dedicated to socially-responsible investing ("Grantham's Optimism on Clean Energy Advances," by Evan Simonoff).
Sunday New York Times October 14, 2018
GMO Climate Change Fund portfolio manager Lucas White comments on companies involved in climate-change mitigation and adaptation ("These Funds Aim to Power Their Returns With Clean Energy," by Tim Gray).
MarketWatch October 11, 2018
Ben Inker comments on risks facing a typical 60/40 stocks/bonds portfolio allocation ("The 'sleep easy' portfolio recommended by your adviser may be riskier than you think," by Brett Arends).
Forbes October 9, 2018
Wallace Forbes interviews Catherine LeGraw, portfolio strategist of GMO's Asset Allocation team ("GMO Forecasts Better Value Outside U.S. Markets").
2018 Zenith Funds Awards October 5, 2018
GMO Australia was recently named Best Alternative Manager for 2018 by Zenith Fund Awards. For more information please see here.
Advisor Perspectives October 2, 2018
Publication carries Emerging Debt Insights paper by Mustafa Ulukan of GMO's Emerging Country Debt team ("Emerging Corporate Debt Fundamentals -- How High Is the Risk?").
The Wall Street Journal September 25, 2018
Tom Hancock, head of GMO's Focused Equity team, on positioning for a time when the rising tide of economic good news recedes ("Health-Care Stocks Lead This Leg of Rally, After Tech Giants' Stumbles" [subscription required for access], by Michael Wursthorn).
CNBC September 21, 2018
CNBC reports on interview of Catherine LeGraw ("Investor who helps manage $71 billion in global assets says US stocks are too expensive," by Thomas Franck).
TD Ameritrade Network September 17, 2018
Martin Emery, portfolio strategist of GMO's Systematic Global Macro team, interviewed on TD Ameritrade's proprietary video network ("Dr. Martin Emery Discusses the State of the Global Economy").
CNBC PRO September 11, 2018
Senior markets commentator Michael Santoli interviews Catherine LeGraw of GMO's Asset Allocation team ("PRO Talks: Catherine LeGraw" [subscription required for access]).
The Economist August 18, 2018
Buttonwood columnist: GMO's "almost fanatical devotion to value" leads to a heavy weighting of emerging-market shares ("Value judgment: The contrarian case for emerging markets").
ThinkAdvisor August 14, 2018
Ben Inker lays out his arguments for "the most attractive asset" ("GMO's Inker: Stick With Emerging Markets Despite Routs," by Bernice Napach).
Financial Times August 13, 2018
Jeremy Grantham: risks of divestment from oil companies have been vastly overstated ("Environmental risk heats up for pension investors" [subscription required for access], by Chris Flood).
The Wall Street Journal July 26, 2018
Ben Inker: "It is dangerous to assume that returns [on stocks] are going to be 7% from here. People have a strong tendency to extrapolate the unsustainable" ("Saving Too Little? Market Is No Savior" [subscription required for access], by James Mackintosh).
Barron's June 25, 2018
From a special report on The ABCs of ESG Investing, Jeremy Grantham highlighted among the most influential people in sustainable investing ("How Jeremy Grantham Is Taking on Climate Change" [subscription required for access], by Leslie Norton).
Barron's July 19, 2018
Barron's on GMO's latest asset-class forecasts ("EM, Cash May Be Best Spots for the Next 7 Years, Says GMO" [subscription required for access], by Reshma Kapadia).
The New York Times July 15, 2018
Ben Inker comments on market response to inflation risks ("Long Dormant, Inflation Reawakens Investors' Fears," by Paul Lim).
Morningstar Magazine June 30, 2018
Ben Inker in roundtable discussion with Notre Dame professor of finance Martijn Cremers and Morningstar director of global passive strategies research Ben Johnson ("Morningstar Conversation: Active vs. Passive Redux: How far should managers go?").
Morningstar June 25, 2018
Video of Jeremy Grantham's keynote address to the 2018 Morningstar Investment Conference ("Watch Jeremy Grantham's 'Race of Our Lives' Speech").
Advisor Perspectives June 19, 2018
Publication carries Emerging Debt Insights white paper by Carl Ross of GMO's Emerging Country Debt team ("Emerging Debt in a Rising Interest Rate Environment").
Financial Advisor June 13, 2018
Coverage of Jeremy Grantham's keynote address to the 2018 Morningstar Investment Conference ("Grantham Says Climate Change, Pollution Put Mankind in 'Race for Our Lives'" by Christopher Robbins).
Meb Faber Research May 23, 2018
Host Meb Faber interviews James Montier of GMO's Asset Allocation team ("James Montier, 'There Really Is a Serious Challenge to Try to Put Together an Investment Portfolio That's Going to Generate Half-Decent Returns on a Forward-Looking Basis'").
Reuters May 09, 2018
Hardik Shah, ESG Practice Manager for GMO: emerging-market investors considering ESG factors can not only improve returns, but serve to improve the financial health of those markets ("Why Asian Investors Are Waking Up to ESG Data").
Financial Times May 08, 2018
Arjun Divecha: "Most emerging markets are now also running fairly sound fiscal and economic policies" ("Argentina's stunning rate rises appear to pay off" [subscription required for access], by Joe Rennison, Robin Wigglesworth and Gideon Long).
Pensions & Investments April 30, 2018
Arjun Divecha, head of GMO's Emerging Markets Equity team: "This particular bout of sanctions ... is not going to have a profound impact on [Russia's] overall economic prospects" ("Sanctions slowing investors' interest in Russia" [subscription required for access], by Sophie Baker).
Barron's April 30, 2018
Matt Kadnar of GMO's Asset Allocation team comments in cover story on the outlook for value-focused investment strategies ("Are Value Stocks Ready to Grow Again?" [subscription required for access], by Reshma Kapadia).
Bloomberg April 17, 2018
Bloomberg on GMO's asset-class forecasts ("Grantham Forecasts Rough Seven Years for Equities, Bonds," by Charles Stein).
The Wall Street Journal April 17, 2018
Arjun Divecha: "We've always said you make more money when things go from truly awful to merely bad ... Russia's relationship with the world is now approaching truly awful" ("Russia's Stocks Show Flaw in Chasing 'Value'" [subscription required for access], by James Mackintosh).
New York Times April 15, 2018
Peter Chiappinelli of GMO's Asset Allocation team: "That bonds are a dampener [on portfolio volatility] is not preordained by God" ("Of Investors, and Their Bondage to Bonds," by Carla Fried).
Bloomberg April 13, 2018
Head of GMO's Emerging Country Debt team Tina Vandersteel noted ("Women Are Winning in Bond Funds. Why Aren't There More of Them?," by Liz McCormick).
New York Times April 13, 2018
Binu George, portfolio strategist for GMO's Emerging Markets Equity team, on the "massive opportunity" for investors in emerging markets ("Finding Emerging Markets Stocks With Social Consciences," by Tim Gray).
MarketWatch April 12, 2018
Amit Bhartia of GMO's Emerging Markets Equity team calculates risk of an "earnings crash" for the emerging-market sector ("Should you invest your retirement savings in emerging markets?," by Mark Hulbert).
Financial Times April 11, 2018
Following the announcement of U.S. sanctions on Russia, Arjun Divecha affirms that GMO is "comfortable with our overweight in Russian equities" ("Rough days for Russian debt..." [registration required for access], by Alexandra Scaggs).
The Economist April 10, 2018
Buttonwood columnist revisits Jeremy Grantham on his market outlook ("An update from Jeremy Grantham" [subscription required for access]).
Bloomberg April 05, 2018
For his Masters in Business series, Bloomberg View columnist Barry Ritholtz interviews Matt Kadnar of GMO's Asset Allocation team ("Matthew Kadnar Talks About His Transition From Law to Finance").
Australian Financial Review March 26, 2018
Neil Constable, head of GMO's Global Equity team, on GMO's effort to ensure stock-picking decisions reflect actual economics of underlying businesses ("GMO's Dr Neil Constable on a mission to update corporate books" [subscription required for access]," by Jonathan Shapiro).
Investment Innovation Institute March 21, 2018
Jeremy Grantham: "You've got to learn to take some risk and hit the ball hard. You don't get that many great opportunities to make money." ("The Biggest Risk in Investing is Trying to Avoid It: Grantham," by Wouter Klijn).
Investment News March 15, 2018
Senior columnist interviews Jeremy Grantham ("GMO's Grantham: No bubble yet, but keep your eyes open," by John Waggoner).
The Wall Street Journal March 04, 2018
Ben Inker: "I believe these tariffs on their own will push inflation higher, and higher inflation is a threat to the valuations of more or less all financial assets today" ("Trump's Tough Talk on Trade Rattles Investors [subscription required for access]," by Michael Wursthorn and Amrith Ramkumar).
Australian Financial Review February 28, 2018
Kim Mayer of GMO's Focused Equity team on opportunities in the climate change sector ("Why clean energy players must tread warily [subscription required for access]," by Karen Maley).
Morningstar February 27, 2018
Walking through an argument on high-risk investment strategies from Ben Inker ("The Case for (and Against) Concentrated Funds," by John Rekenthaler).
Business Wire February 26, 2018
GMO Announces Partnership with St. James’s Place; Responds to US Private Wealth Demand (click here to read article).
ThinkAdvisor February 20, 2018
Ben Inker explores whether a portfolio of concentrated, high tracking error, "high conviction" strategies might maximize the probability of meeting or beating a target return ("GMO's Inker: How to Chase Alpha Like Your Life Depends on It," by Janet Levaux).
Financial Times February 13, 2018
James Montier: "Fund managers for the most part all agree that the US market is expensive but still they choose to own equities -- a cynical career-risk-driven position if ever there was one" ("The fully invested bear [subscription required for access]," by Dan McCrum).
Reuters February 05, 2018
Catherine LeGraw: emerging market value stocks "far more attractive than anything else we can find" ("Emerging markets stocks resilient as U.S. sells off," by Rodrigo Campos).
PBS: Consuelo Mack WealthTrack January 26, 2018
Consuelo Mack interviews Jeremy Grantham ("Riding a Market Melt-Up Then Coping With the Melt-Down with Legendary Investor, Jeremy Grantham").
Financial Times January 22, 2018
Arjun Divecha: China's shadow-banking system has grown too quickly ("China Bulls Beat the Shorts for Now [subscription required for access]," by Robin Wigglesworth and Gabriel Wildau).
The New York Times January 14, 2018
Catherine LeGraw notes that investors need not limit themselves to staid industries to gain exposure to attractively priced emerging market stocks ("Bargain Hunters Turn to Emerging Market Stocks," by Paul Lim).
Morningstar January 08, 2018
GMO's real-return expectations for most equity categories are negative, with value-oriented emerging-markets stocks an exception ("Experts Forecast Long-Term Stock and Bond Returns: 2018 Edition," by Christine Benz).
The Wall Street Journal January 08, 2018
GMO favors cheaper emerging-market stocks ("How to Survive a Stock Market Bubble [subscription required for access]," by James Mackintosh).
Financial Times January 05, 2018
Jeremy Grantham on market bubbles ("Global stocks celebrate 2018 with record highs: Renowned strategist warns bull markets show signs of entering 'blow-off' phase [subscription required for access]," by Stephen Smith).
The Economist January 04, 2018
Buttonwood column on Jeremy Grantham's market outlook ("A wild ride in 2018: Is the bubble only starting?" [subscription required for access]).
Barron's January 03, 2018
Jeremy Grantham on price acceleration in gauging market bubbles ("Guess Who's Bubble Spotting Now?" [subscription required for access]).
Economic Times January 01, 2018
Indian daily interviews Arjun Divecha on his view of India and other emerging markets ("Populist measures will be good for the stock market: Arjun Divecha, GMO," by Sanam Mirchandani).